School of Physiotherapy, Royal College of Surgeons in Ireland, Dublin, Ireland.
Arch Phys Med Rehabil. 2013 Feb;94(2):302-14. doi: 10.1016/j.apmr.2012.09.030. Epub 2012 Oct 16.
OBJECTIVES: To determine the effectiveness of exercise therapy (ET) compared with ET with adjunctive manual therapy (MT) for people with hip osteoarthritis (OA); and to identify if immediate commencement of treatment (ET or ET+MT) was more beneficial than a 9-week waiting period for either intervention. DESIGN: Assessor-blind randomized controlled trial with a 9-week and 18-week follow-up. SETTING: Four academic teaching hospitals in Dublin, Ireland. PARTICIPANTS: Patients (N=131) with hip OA recruited from general practitioners, rheumatologists, orthopedic surgeons, and other hospital consultants were randomized to 1 of 3 groups: ET (n=45), ET+MT (n=43), and waitlist controls (n=43). INTERVENTIONS: Participants in both the ET and ET+MT groups received up to 8 treatments over 8 weeks. Control group participants were rerandomized into either ET or ET+MT groups after 9 week follow-up. Their data were pooled with original treatment group data: ET (n=66) and ET+MT (n=65). MAIN OUTCOME MEASURES: The primary outcome was the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) physical function (PF) subscale. Secondary outcomes included physical performance, pain severity, hip range of motion (ROM), anxiety/depression, quality of life, medication usage, patient-perceived change, and patient satisfaction. RESULTS: There was no significant difference in WOMAC PF between the ET (n=66) and ET+MT (n=65) groups at 9 weeks (mean difference, .09; 95% confidence interval [CI] -2.93 to 3.11) or 18 weeks (mean difference, .42; 95% CI, -4.41 to 5.25), or between other outcomes, except patient satisfaction with outcomes, which was higher in the ET+MT group (P=.02). Improvements in WOMAC, hip ROM, and patient-perceived change occurred in both treatment groups compared with the control group. CONCLUSIONS: Self-reported function, hip ROM, and patient-perceived improvement occurred after an 8-week program of ET for patients with OA of the hip. MT as an adjunct to exercise provided no further benefit, except for higher patient satisfaction with outcome.
目的:比较运动疗法(ET)与运动疗法加辅助手法治疗(MT)治疗髋骨关节炎(OA)患者的疗效;并确定即刻开始治疗(ET 或 ET+MT)是否比两种干预措施的 9 周等待期更有益。
设计:评估者盲法随机对照试验,随访 9 周和 18 周。
地点:爱尔兰都柏林的 4 所学术教学医院。
参与者:招募自全科医生、风湿病学家、骨科医生和其他医院顾问的髋 OA 患者(N=131)被随机分为 3 组之一:ET(n=45)、ET+MT(n=43)和等待对照(n=43)。
干预措施:ET 和 ET+MT 组的参与者在 8 周内接受多达 8 次治疗。对照组参与者在 9 周随访后重新随机分为 ET 或 ET+MT 组。他们的数据与原始治疗组数据(ET,n=66;ET+MT,n=65)合并。
主要结局测量:主要结局是西安大略和麦克马斯特大学骨关节炎指数(WOMAC)躯体功能(PF)子量表。次要结局包括身体表现、疼痛严重程度、髋关节活动范围(ROM)、焦虑/抑郁、生活质量、药物使用、患者感知变化和患者满意度。
结果:在 9 周(平均差异,0.09;95%置信区间[CI],-2.93 至 3.11)或 18 周(平均差异,0.42;95%CI,-4.41 至 5.25)时,ET(n=66)和 ET+MT(n=65)组之间的 WOMAC PF 无显著差异,除了患者对治疗结果的满意度,ET+MT 组更高(P=.02)。与对照组相比,两组治疗组的 WOMAC、髋关节 ROM 和患者感知改善均有所改善。
结论:对于髋骨 OA 患者,8 周的运动疗法方案后可出现自我报告的功能、髋关节 ROM 和患者感知的改善。作为运动疗法的辅助治疗,MT 除了提高患者对治疗结果的满意度外,并无进一步的益处。
Arch Phys Med Rehabil. 2011-12-21
Arch Phys Med Rehabil. 2010-1
Front Drug Deliv. 2023-7-20
J Funct Morphol Kinesiol. 2025-4-8
J Funct Morphol Kinesiol. 2024-12-7
Healthcare (Basel). 2023-9-21
Osteoarthr Cartil Open. 2023-1-19
Cochrane Database Syst Rev. 2022-10-17